The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORSBDB
Biogen Ma
MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOFBDB
Goharmony Therapeutics (Shenzhen) Co.
Urea compounds and compositions as SMARCA2/BRM ATPase inhibitorsBDB
Novartis
6-fluoro-2-methylbenzo[d]thiazol-5-yl compoundsBDB
Eli Lilly
LXR agonists and uses thereofBDB
Rgenix
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitorsBDB
Merck Sharp & Dohme
Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast a-glucosidase, acetylcholinesterase and butyrylcholinesterase.BDB
Gc University
1,2,5-substituted benzimidazoles as FLAP modulatorsBDB
Janssen Pharmaceutica
Acyclic amine inhibitors of nucleoside phosphorylases and hydrolasesBDB
Industrial Research
Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors.BDB
University of Maryland
Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors.BDB
Universidad De Navarra